Urologic cancer in Japan: role of Japan at the frontier of issues in Asia - Wikidata - wikimedia - TriplyDB

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

http://www.wikidata.org/entity/Q26798350

about

Evolution of the Histo-Epidemiological Profile of Urological Cancers in Togo Prostate cancer trends in Asia.Validation of American Joint Committee on Cancer eighth staging system among prostate cancer patients treated with radical prostatectomy.

P2860

Q38874374-EAC21A38-30F1-4297-B676-77956BAA1558 Q39374516-27ECBEE3-005D-42F8-9B4C-61EF6C6EE347 Q49423656-E769544B-B490-47FA-985C-188ABC08F487

P2860

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

http://www.wikidata.org/entity/Q26798350

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@ast

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@en

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@nl

type

label

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@ast

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@en

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@nl

prefLabel

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@ast

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@en

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@nl

P1433

Q26798350-555E99BB-ADAD-4C25-8C74-5B94B3AC5BC5

P1476

Q26798350-670F6A7D-9840-4AF5-A050-029840FC2C49

P2093

Q26798350-8012EF85-C77B-4191-AF03-F5DCBB41B499

P2860

Q26798350-13C3C6C8-8841-4A7E-B4C7-9A4215B234CD

Q26798350-2E971A1E-2A91-4FB3-836A-1FD5DDAC61CF

Q26798350-37C3107A-7A38-48DF-B6AE-115F69EBCE7C

Q26798350-4463AD8A-6880-48D9-9F56-35D015476300

Q26798350-613B1FCD-0EE1-476B-81CA-C05F6AA7D9FB

Q26798350-7D7EF2F7-8495-483D-A2EB-7DEBD21A9E8B

Q26798350-83CA5C05-B7AD-49B8-9317-A6BF9E72A76A

Q26798350-865FB176-8768-40D6-9636-4BCCC85D690E

Q26798350-96615956-CFB5-457A-B3F1-BACCE6510AD8

Q26798350-B99ED6B9-2279-43D8-B1CA-28C5AC9E90FE

P304

Q26798350-12AC1C5F-4281-46F9-9F84-E69575F4422F

P31

Q26798350-48172E98-BBF5-4690-A9BD-E437284D8107

P356

Q26798350-4F5DBADA-BD19-4372-AF17-2C6BC9F671C9

P407

Q26798350-51F7BE03-FB32-4B30-9C94-EE1EA61AF4D2

P433

Q26798350-FC4BEFF8-A071-4248-A8EC-1F80C3392D75

P478

Q26798350-5BEFE208-4099-42FE-8E7E-45EDB82F1316

P577

Q26798350-1E82480A-8C93-4434-AD97-CC78E6BE119E

P5875

Q26798350-C782959A-40B2-4412-9C58-86DECDABE6EC

P698

Q26798350-CE4F6412-2CA7-44CA-A8CA-CA57BB1EFC6F

P356

P1433

Japanese Journal of Clinical Oncology

P1476

Urologic cancer in Japan: role of Japan at the frontier of issues in Asia

@en

P2093

Hideyuki Akaza

http://www.w3.org/2001/XMLSchema#string

P2860

Real-world use of sunitinib in Japanese patients with advanced renal cell carcinoma: efficacy, safety and biomarker analyses in 1689 consecutive patients.

Enzalutamide in metastatic prostate cancer before chemotherapy.

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.

Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.

Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome".

Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient.

The hallmarks of castration-resistant prostate cancers.

B7-H1/PD-1 blockade therapy in urological malignancies: current status and future prospects.

Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.

Cross-boundary cancer studies at the University of Tokyo: Deciphering the frontlines of medicine.

P304

23-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYV123

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280997935

http://www.w3.org/2001/XMLSchema#string

P698

26268998

http://www.w3.org/2001/XMLSchema#string